News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mattes Glenn R.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2022 |
4
| Mattes Glenn R. (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 16,000 shares
@ $4.78, valued at
$76.5k
|
|
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Mattes Glenn R. (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 50,000 shares
@ $17.04, valued at
$852k
Exercised 50,000 options to buy
@ $2.5, valued at
$125k
|
|
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2020 |
4
| Mattes Glenn R. (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 30,000 shares
@ $15.33, valued at
$459.9k
Exercised 30,000 options to buy
@ $2.5, valued at
$75k
|
|
| 11/13/2020 |
4
| Mattes Glenn R. (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Sold 108,830 shares
@ $14.995, valued at
$1.6M
Exercised 108,830 options to buy
@ $2.5, valued at
$272.1k
|
|
| 08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| Mattes Glenn R. (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Granted 25,214 options to buy
@ $5, valued at
$126.1k
|
|
| 10/30/2019 |
4/A
| Mattes Glenn R. (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $5, valued at
$50k
Bought 10,000 shares
@ $5, valued at
$50k
Granted 332,868 options to buy
@ $5, valued at
$1.7M
|
|
| 10/29/2019 |
4
| Mattes Glenn R. (President and CEO) has filed a Form 4 on TFF Pharmaceuticals, Inc.|
Txns:
| Bought 10,000 shares
@ $5, valued at
$50k
Granted 332,868 options to buy
@ $5, valued at
$1.7M
|
|
| 10/24/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/28/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/06/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/31/2013 |
4
| Mattes Glenn R. (President & CEO) has filed a Form 4 on Arno Therapeutics, Inc|
Txns:
| Converted 22,218 shares
@ $2.4, valued at
$53.3k
Granted 1,666 shares
@ $2.4, valued at
$4k
Bought 20,833 shares
@ $0
Converted 20,833 options to buy
@ $2.4, valued at
$50k
Disposed/sold 20,833 options to buy
@ $2.4, valued at
$50k
Granted 20,833 options to buy
@ $2.4, valued at
$50k
Bought 20,833 options to buy
@ $4, valued at
$83.3k
Bought 20,833 options to buy
@ $2.4, valued at
$50k
|
|
| 05/30/2013 |
4
| Mattes Glenn R. (President & CEO) has filed a Form 4 on Arno Therapeutics, Inc|
Txns:
| Acquired 3,222 shares
@ $0.3, valued at
$966.6 |
|
| 05/07/2013 |
4
| Mattes Glenn R. (President & CEO) has filed a Form 4 on Arno Therapeutics, Inc|
Txns:
| Acquired 3,333 shares
@ $0.3, valued at
$999.9 |
|
|
|